Search

everythinglearnresearchcommunity

for

Search:↓

Scientists have created a new hair loss treatment using ultrasound to deliver gene-editing particles, which resulted in up to 90% hair regrowth in mice.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Polyamines help fix DNA damage accurately in cells.

Regenerative pharmacology, which combines drugs with regenerative medicine, shows promise for repairing damaged body parts and needs more interdisciplinary research.

The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.

Finasteride reduces Tourette syndrome symptoms, but results may be limited due to potential biases.

The enzyme 17β-HSD type 2 mainly performs oxidation in human sebaceous glands, which may help protect against acne.

Hair problems can be caused by genetics or the environment, and treatment should focus on the cause and reducing hair damage.

Lymphatic vessels develop from various cell types and mechanisms, not just veins.

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

Surface Plasmon Resonance is a useful tool for studying protein interactions and has potential for future technological advancements.

Eph/ephrin signaling is important for skin cell behavior and could be targeted to treat skin diseases.

Some hair loss disorders are caused by genetic mutations affecting hair growth.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

Pyrene excimer nucleic acid probes are promising for detecting biomolecules accurately with potential for biological research and drug screening.

Gene therapy has potential as a future treatment for Hutchinson-Gilford progeria syndrome.

Finasteride may help reduce symptoms in male Tourette syndrome patients.

Genetic differences affect COVID-19 severity and treatment development.

Hair proteins have weak spots in their α-helical segments.

pH, calcium, and reactive oxygen species regulate plant cell growth, with key roles for NADPH oxidases and plasma membrane H+-ATPases.

The study concludes that the EDA2R gene is activated by p53 during chemotherapy but is not necessary for chemotherapy-induced hair loss.

The study developed a tool to predict how gut microbes process foods and drugs, showing that similar compounds often share metabolic pathways and effects.

High lactate dehydrogenase activity is not necessary for the growth of squamous cell carcinoma.

The protein SLC1A3 is important for activating skin stem cells and is necessary for normal hair and skin growth in mice.

ROOT HAIR SPECIFIC 10 (RHS10) reduces the length of root hairs in Arabidopsis plants.

Essential-oils-cobalt improves goat growth and product quality.

MicroRNAs are important for skin health and could be targets for new skin disorder treatments.

The document describes a woman with familial Parkinson's disease due to a genetic mutation, showing severe symptoms and poor response to treatment, and suggests finasteride may help reduce symptoms in Tourette syndrome.

Immune cells help regulate hair growth, and better understanding this can improve hair loss treatments.

Certain microRNAs are more common in balding areas and might be involved in male pattern baldness.